STAT3 and intrahepatic cholangiocarcinoma: Moreover, the inhibition of CCL18-mediated STAT3 phosphorylation, through immune responsive gene 1 (IRG1) overexpression, can inhibit macrophages M2-like polarization and impair the progression of intrahepatic cholangiocarcinoma (ICC) [89] (Table 4).